交易 Verastem - VSTM CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.14 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.026151% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003929% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Verastem Inc ESG Risk Ratings
High Medium Low Negligible
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Sep 25, 2023 | 9.33 | -0.03 | -0.32% | 9.36 | 9.56 | 9.16 |
Sep 22, 2023 | 9.61 | 0.45 | 4.91% | 9.16 | 9.78 | 9.16 |
Sep 21, 2023 | 9.43 | 0.27 | 2.95% | 9.16 | 9.50 | 9.16 |
Sep 20, 2023 | 9.46 | 0.10 | 1.07% | 9.36 | 9.55 | 9.19 |
Sep 19, 2023 | 9.46 | -0.34 | -3.47% | 9.80 | 9.81 | 9.40 |
Sep 18, 2023 | 9.79 | 0.33 | 3.49% | 9.46 | 10.18 | 9.25 |
Sep 15, 2023 | 9.81 | 0.32 | 3.37% | 9.49 | 9.86 | 9.16 |
Sep 14, 2023 | 9.65 | 0.21 | 2.22% | 9.44 | 9.69 | 9.36 |
Sep 13, 2023 | 9.48 | -0.09 | -0.94% | 9.57 | 9.73 | 9.38 |
Sep 12, 2023 | 9.77 | 0.14 | 1.45% | 9.63 | 9.98 | 9.46 |
Sep 11, 2023 | 9.75 | 0.08 | 0.83% | 9.67 | 9.84 | 9.50 |
Sep 8, 2023 | 9.66 | -0.03 | -0.31% | 9.69 | 9.70 | 9.46 |
Sep 7, 2023 | 9.73 | 0.06 | 0.62% | 9.67 | 9.87 | 9.46 |
Sep 6, 2023 | 9.86 | 0.29 | 3.03% | 9.57 | 9.90 | 9.46 |
Sep 5, 2023 | 9.72 | 0.24 | 2.53% | 9.48 | 9.79 | 9.48 |
Sep 1, 2023 | 9.82 | 0.11 | 1.13% | 9.71 | 9.91 | 9.47 |
Aug 31, 2023 | 9.72 | -0.09 | -0.92% | 9.81 | 10.02 | 9.66 |
Aug 30, 2023 | 9.90 | 0.19 | 1.96% | 9.71 | 10.02 | 9.66 |
Aug 29, 2023 | 9.76 | -0.10 | -1.01% | 9.86 | 10.18 | 9.71 |
Aug 28, 2023 | 9.88 | -0.31 | -3.04% | 10.19 | 10.50 | 9.67 |
Verastem Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, September 26, 2023 | ||
时间(协调世界时) (UTC) 13:55 | 国家 US
| 事件 Verastem Inc at Cantor Fitzgerald Global Healthcare Conference Verastem Inc at Cantor Fitzgerald Global Healthcare ConferenceForecast(预报) -上一页 - |
Wednesday, November 1, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q3 2023 Verastem Inc Earnings Release Q3 2023 Verastem Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 2.596 | 2.053 | 88.516 | 17.456 | 26.718 |
总营业费用 | 75.533 | 63.462 | 139.456 | 149.797 | 121.501 |
销售/一般/行政费用,总计 | 24.975 | 24.115 | 58.655 | 101.212 | 77.265 |
研究与开发 | 50.558 | 39.347 | 40.876 | 45.778 | 43.648 |
营业收入 | -72.937 | -61.409 | -50.94 | -132.341 | -94.783 |
利息收入(费用),非经营净值 | -0.922 | -9.791 | -15.279 | -16.227 | -3.207 |
税前净收入 | -73.812 | -71.2 | -67.532 | -149.209 | -72.434 |
税后净收入 | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
未计算非常项目前的净收益 | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
净收入 | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
普通股股东可获收益 (不含非经常性项目) | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
普通股股东可获收益 (含非經常性項目) | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
摊薄净收入 | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
摊薄后加权平均股 | 16.1378 | 14.5332 | 12.777 | 6.21458 | 5.41328 |
扣除特别项目的每股摊薄盈利 | -4.57385 | -4.89911 | -5.30062 | -24.0095 | -13.3808 |
每股正常摊薄盈利 | -4.56709 | -4.89636 | -4.98623 | -24.5244 | -13.3808 |
收入 | 2.596 | 2.053 | 88.516 | 17.456 | 26.718 |
收入成本,共计 | 0 | 0 | 32.952 | 1.238 | 0.165 |
毛利 | 2.596 | 2.053 | 55.564 | 16.218 | 26.553 |
Depreciation / Amortization | 0 | 0 | 0.793 | 1.569 | 0.423 |
其他,净值 | 0.047 | 0 | -1.313 | -0.641 | 25.556 |
异常费用(收入) | 0 | 0 | 6.18 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
收入成本,共计 | 0 | ||||
毛利 | 0 | ||||
总营业费用 | 20.292 | 19.344 | 16.846 | 17.709 | 21.402 |
销售/一般/行政费用,总计 | 7.399 | 7.329 | 6.106 | 6.421 | 6.514 |
研究与开发 | 12.893 | 12.015 | 10.74 | 11.288 | 14.888 |
Depreciation / Amortization | 0 | ||||
营业收入 | -20.292 | -19.344 | -16.846 | -17.709 | -21.402 |
利息收入(费用),非经营净值 | 0.001 | 0.207 | 0.045 | -0.401 | -0.556 |
税前净收入 | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
税后净收入 | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
未计算非常项目前的净收益 | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
净收入 | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
普通股股东可获收益 (不含非经常性项目) | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
普通股股东可获收益 (含非經常性項目) | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
摊薄净收入 | -24.281 | -15.714 | -16.808 | -18.09 | -21.952 |
摊薄后加权平均股 | 17.732 | 16.7226 | 17.0516 | 16.4286 | 15.538 |
扣除特别项目的每股摊薄盈利 | -1.36933 | -0.93969 | -0.98571 | -1.10113 | -1.4128 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -1.36933 | -0.93969 | -0.97932 | -1.10113 | -1.4128 |
其他,净值 | -3.99 | 3.423 | -0.007 | 0.02 | 0.006 |
异常费用(收入) | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 92.87 | 105.74 | 144.938 | 84.961 | 253.259 |
现金和短期投资 | 87.894 | 100.256 | 141.226 | 75.506 | 249.653 |
现金等价物 | 74.933 | 21.252 | 67.782 | 43.514 | 129.867 |
短期投资 | 12.961 | 79.004 | 73.444 | 31.992 | 119.786 |
应收账款总额,净额 | 0.031 | 0.516 | 0.239 | 2.524 | 0.306 |
預付的費用 | 4.945 | 4.968 | 3.473 | 3.835 | 2.973 |
總資産 | 95.05 | 108.662 | 154.349 | 145.046 | 277.236 |
物業/廠房/設備,總計 - 淨額 | 1.881 | 2.512 | 3.142 | 4.024 | 1.369 |
物業/廠房/設備,總計 - 總額 | 3.411 | 4.187 | 4.611 | 4.962 | 1.878 |
累計折舊,總計 | -1.53 | -1.675 | -1.469 | -0.938 | -0.509 |
其他長期資産,總計 | 0.299 | 0.41 | 0.274 | 36.053 | 1.031 |
流動負債總額 | 21.663 | 18.59 | 17.093 | 29.89 | 37.077 |
應付賬款 | 4.901 | 2.302 | 1.875 | 9.655 | 10.253 |
預提費用 | 15.777 | 16.288 | 15.218 | 19.785 | 21.108 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.71 | 0 | 0.45 | ||
負債總額 | 47.659 | 21.103 | 39.075 | 137.872 | 152.937 |
長期債務總額 | 24.526 | 0.249 | 19.051 | 103.623 | 114.737 |
其他負債,總計 | 1.47 | 2.264 | 2.931 | 4.359 | 1.123 |
總權益 | 47.391 | 87.559 | 115.274 | 7.174 | 124.299 |
普通股 | 0.02 | 0.019 | 0.017 | 0.008 | 0.007 |
額外實收資本 | 784.894 | 751.217 | 707.715 | 531.937 | 499.741 |
留存收益(累計赤字) | -737.523 | -663.711 | -592.511 | -524.785 | -375.576 |
其他權益,總計 | 0 | 0.034 | 0.053 | 0.014 | 0.127 |
總負債和股東權益 | 95.05 | 108.662 | 154.349 | 145.046 | 277.236 |
已發行普通股總數 | 16.7111 | 15.4399 | 14.2041 | 6.67623 | 6.15025 |
長期債務 | 24.526 | 0.249 | 19.051 | 103.623 | 114.737 |
應收賬款 - 貿易,淨額 | 0.031 | 0.516 | 0.239 | 2.524 | 0.306 |
總庫存 | 0 | 3.096 | 0.327 | ||
無形資産,淨額 | 0 | 20.008 | 21.577 | ||
長期債務的當前部分/資本租賃 | 0.275 | 0 | 5.716 | ||
長期投資 | 0 | 5.995 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 118.893 | 92.87 | 108.759 | 97.875 | 113.439 |
现金和短期投资 | 111.204 | 87.894 | 103.976 | 94.307 | 106.278 |
现金等价物 | 97.26 | 74.933 | 78.166 | 63.95 | 46.687 |
短期投资 | 13.944 | 12.961 | 25.81 | 30.357 | 59.591 |
应收账款总额,净额 | 0 | 0.031 | 0.074 | 0.131 | 2.644 |
應收賬款 - 貿易,淨額 | 0 | 0.031 | 0.074 | 0.131 | 2.644 |
預付的費用 | 7.689 | 4.945 | 4.709 | 3.437 | 4.517 |
總資産 | 120.877 | 95.05 | 111.095 | 100.409 | 116.148 |
物業/廠房/設備,總計 - 淨額 | 1.707 | 1.881 | 2.048 | 2.209 | 2.363 |
長期投資 | |||||
其他長期資産,總計 | 0.277 | 0.299 | 0.288 | 0.325 | 0.346 |
流動負債總額 | 22.359 | 21.663 | 21.873 | 20.092 | 16.886 |
應付賬款 | 4.903 | 4.901 | 5.359 | 1.706 | 2.896 |
預提費用 | 14.767 | 15.777 | 15.549 | 18.386 | 13.99 |
應付票據/短期債務 | 1.004 | 0 | 0 | 0 | 0 |
負債總額 | 66.693 | 47.659 | 48.222 | 46.517 | 43.377 |
長期債務總額 | 39.574 | 24.526 | 24.667 | 24.538 | 24.412 |
長期債務 | 39.574 | 24.526 | 24.667 | 24.538 | 24.412 |
其他負債,總計 | 4.76 | 1.47 | 1.682 | 1.887 | 2.079 |
總權益 | 54.184 | 47.391 | 62.873 | 53.892 | 72.771 |
普通股 | 0.02 | 0.02 | 0.021 | 0.019 | 0.019 |
額外實收資本 | 786.236 | 784.894 | 783.606 | 756.628 | 753.538 |
留存收益(累計赤字) | -753.237 | -737.523 | -720.715 | -702.625 | -680.673 |
其他權益,總計 | 0.006 | 0 | -0.039 | -0.13 | -0.113 |
總負債和股東權益 | 120.877 | 95.05 | 111.095 | 100.409 | 116.148 |
已發行普通股總數 | 16.7357 | 16.7111 | 17.5063 | 15.6338 | 15.5269 |
其他流動負債,總計 | 1.403 | 0.71 | 0.965 | ||
長期債務的當前部分/資本租賃 | 0.282 | 0.275 | |||
Redeemable Preferred Stock | 21.159 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -73.812 | -71.2 | -67.726 | -149.209 | -72.434 |
经营活动产生的现金 | -63.673 | -53.502 | -33.506 | -138.518 | -74.515 |
经营活动产生的现金 | 0.118 | 0.206 | 0.531 | 0.429 | 0.996 |
非现金物品 | 6.121 | 16.908 | 21.261 | 16.492 | -17.15 |
已付现金利息 | 1.536 | 1.007 | 5.126 | 12.424 | 2.107 |
营运资金的变化 | 3.9 | 0.584 | 11.635 | -7.799 | 13.65 |
投资活动产生的现金 | 66.185 | 0.087 | -47.363 | 89.613 | -138.377 |
资本支出 | 0 | -0.196 | -0.033 | -0.007 | -23.507 |
其他投资现金流量项目,总计 | 66.185 | 0.283 | -47.33 | 89.62 | -114.87 |
融资活动产生的现金 | 51.784 | 6.885 | 69.63 | -2.441 | 261.162 |
融资现金流项目 | 0 | -0.925 | -2.048 | -0.506 | |
股票的发行(报废),净额 | 27.636 | 7.81 | 109.044 | 0.569 | 105.965 |
债务的发行(退还),净额 | 24.148 | 0 | -37.366 | -2.504 | 155.197 |
现金净变化 | 54.296 | -46.53 | -11.239 | -51.346 | 48.27 |
Amortization | 0 | 0 | 0.793 | 1.569 | 0.423 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.714 | -73.812 | -57.004 | -38.914 | -16.962 |
Cash From Operating Activities | -20.286 | -63.673 | -47.057 | -31.975 | -19.281 |
Cash From Operating Activities | 0.03 | 0.118 | 0.089 | 0.059 | 0.03 |
Non-Cash Items | -2.194 | 6.121 | 4.878 | 3.443 | 1.626 |
Cash Interest Paid | 0 | ||||
Changes in Working Capital | -2.408 | 3.9 | 4.98 | 3.437 | -3.975 |
Cash From Investing Activities | -0.804 | 66.185 | 53.16 | 48.513 | 19.264 |
Capital Expenditures | 0 | 0 | 0 | 0 | |
Other Investing Cash Flow Items, Total | -0.804 | 66.185 | 53.16 | 48.513 | 19.264 |
Cash From Financing Activities | 44.05 | 51.784 | 51.784 | 26.16 | 25.452 |
Financing Cash Flow Items | 1.004 | 0 | 0 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 28.128 | 27.636 | 27.636 | 2.012 | 0.68 |
Net Change in Cash | 22.96 | 54.296 | 57.887 | 42.698 | 25.435 |
Amortization | 0 | ||||
Issuance (Retirement) of Debt, Net | 14.918 | 24.148 | 24.148 | 24.148 | 24.772 |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投资
交易规模(杠杆 x 投资):
開倉
平仓
做空 做多
Verastem Company profile
关于 Verastem Inc
Verastem, Inc.是一家生物制药公司。 公司的产品线主要集中在抑制癌症中促进癌细胞生存和肿瘤生长的关键信号通路的抗癌药物,特别是RAF/MEK抑制和FAK抑制。 其先进的候选产品VS-6766和defactinib正在进行临床前和临床研究,用于治疗各种实体肿瘤,包括低度浆液性卵巢癌(LGSOC)、非小细胞肺癌(NSCLC)、结直肠癌(CRC)、胰腺癌、葡萄膜黑色素瘤和子宫内膜癌。 VS-6766是一种口服的小分子RAF/MEK钳。 VS-6766是一种双重RAF/MEK钳,既能阻断MEK的激酶活性,又能阻断RAF对MEK的磷酸化能力。 Defactinib是一种口服的小分子FAK和富脯氨酸酪氨酸激酶(PYK2)抑制剂,正在被评估为各种实体瘤的潜在联合疗法。
Industry: | Bio Therapeutic Drugs |
117 Kendrick St Ste 500
CAMBRIDGE
MASSACHUSETTS 02142
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球555,000万多名交易者的一份子,选择利用Capital.com进行交易吧。